Alflutinib is a selective small molecule inhibitor of anaplastic lymphoma kinase (ALK) that is primarily used as an anticancer agent in the treatment of non-small cell lung cancer and other ALK-positive… Read more
Alflutinib is a selective small molecule inhibitor of anaplastic lymphoma kinase (ALK) that is primarily used as an anticancer agent in the treatment of non-small cell lung cancer and other ALK-positive malignancies. This category of pharmaceutical reference standards includes the parent drug alongside its relevant derivatives, such as stable isotope labelled compounds like Alflutinib-d6 and synthesis-related impurities like Alflutinib impurity 1 HCl. These high-quality materials are essential for pharmaceutical laboratories conducting impurity profiling, method validation, and rigorous quality control testing. By providing reliable analytical standards, these compounds enable accurate identification and precise quantification of the active pharmaceutical ingredient and its associated substances throughout the drug development and manufacturing lifecycle. Scientists utilize these reference materials to ensure regulatory compliance and to verify the purity and stability of drug formulations in complex biological and chemical matrices.